This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: National University Corporation Tokai National Higher Education and Research System, Sowakai Medical Foundation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yukihiro Shiraki: Innovator in Cancer Treatment
Introduction
Yukihiro Shiraki is a prominent inventor based in Aichi, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on the creation of antibodies that can be used in therapeutic applications for cancer patients.
Latest Patents
Yukihiro Shiraki holds a patent for an "ANTI-MEFLIN ANTIBODY FOR USE IN TREATMENT OF CANCER IN SUBJECT HAVING CANCER, AND PHARMACEUTICAL COMPOSITION COMPRISING THE ANTIBODY." This patent represents a crucial advancement in the fight against cancer, showcasing his dedication to improving patient outcomes.
Career Highlights
Throughout his career, Yukihiro Shiraki has worked with esteemed organizations such as Sowakai Medical Foundation and the National University Corporation Tokai National Higher Education and Research System. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Yukihiro has collaborated with notable colleagues, including Shino Manabe and Makoto Matsuyama. These partnerships have further enhanced his research capabilities and have led to significant advancements in cancer treatment methodologies.
Conclusion
Yukihiro Shiraki's innovative work in developing cancer treatment antibodies highlights his commitment to advancing medical science. His contributions are paving the way for new therapeutic options for patients battling cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile